MEDIPOST, KOREA: leading a “new era of mass-manufactured … stem cell drug products” to treat knee and cartilage defects, neurodegenerative diseases including Alzheimer’s (AD) and ALS, pulmonary disorders, and blood diseases. Using non-controversial cells from unrelated umbilical cord cell banks. In phase I trials in ALzheimer’s.
http://www.medi-post.com/am_1.asp
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022